Clinical Trial
Published on 08 Dec 2025
Study to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial
in Clinical Nutrition
Frontiers in Nutrition
doi 10.3389/fnut.2025.1701611
- 2,394 views
